Amsterdam based venture capital firms investing in early stage startups

Finch Capital is a late-stage venture capital firm based in Amsterdam that specializes in investing in high-growth financial technology companies led by exceptional entrepreneurs who have achieved annual recurring revenues of EUR 2-5 million.

Newion is an Amsterdam-based venture capital firm specializing in early stage investments in B2B software companies, with a particular focus on seed funding.

Inkef is a European venture capital firm that specializes in early-stage investments in technology and healthcare companies, with a particular focus on those based in Amsterdam.

Revo Capital is the largest venture capital firm in Turkey, managing a fund of $188M. With a focus on technology-driven startups in Turkey, Eastern Europe, and the Baltics, they are currently investing their €90M second fund in Series A+ startups.

Prime Ventures is a venture capital firm based in Amsterdam that specializes in investing in technology companies at various stages, including early stage, late stage, private equity, and seed. With its extensive capital, experience, and network, Prime Ventures actively supports and guides its portfolio companies towards becoming global category leaders.

henQ is an Amsterdam-based venture capital firm that specializes in providing early-stage funding for innovative B2B software startups that stand out from the crowd. They primarily focus on supporting companies in their early stages, from seed funding to venture capital, and have a particular interest in unique and unconventional ideas in the B2B software industry.

Rubio Impact Ventures operates as a dedicated venture fund, concentrating on early and growth stage enterprises that make a positive impact on society and the environment.

M Ventures is a venture capital firm based in Amsterdam that focuses on investing in early and late-stage innovative technologies and products that have the potential to greatly influence Merck's core business areas, making it a prominent player in both corporate and traditional venture capital.